Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

This study tested a new injectable medication called Efsubaglutide Alfa for people with type 2 diabetes whose blood sugar was still too high despite diet and exercise. It involved 59 participants and compared two different dosing schedules—one shot every two weeks versus one shot…